Aldatu Biosciences, Inc.
Publicly observedWatertown, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Watertown | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Aldatu Biosciences, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | N29WVC3UJCB9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Aug 2022Publicly observed
NIH SBIR/STTR award: PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
USD 996,962.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant24 Mar 2021Publicly observed
NIH SBIR/STTR award: PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
USD 960,045.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant24 Mar 2021Publicly observed
NIH SBIR/STTR award: PANDAA for universal, pan-lineage molecular detection of Crimean-Congo Hemorrhagic Fever virus.
USD 975,023.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.